Aardvark Therapeutics Q2 EPS Beats Estimate
Aardvark Therapeutics reports Q2 EPS of $(0.66), beating the $(0.91) estimate
Site Search
Search market news
Find public news by keyword, exact ticker, category and date.
Matching instruments
Open a ticker page for its news coverage. The news search below stays a text search.